Evaluation of glucagon secretion during 75g-OGTT to predict requirement of insulin therapy, perinatal outcome, and development of type 2 diabetes after delivery in Japanese patients with gestational diabetes.

Evaluation of glucagon secretion during 75g-OGTT to predict requirement of insulin therapy, perinatal outcome, and development of type 2 diabetes after delivery in Japanese patients with gestational diabetes. - Glucagon secretion in GDM

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034337

Enrollment

100

Registered

2018-10-01

Start date

2014-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational diabetes

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Pregnant women diagnosed with gestational diabetes defined by IADPSG criteria during pregnancy.

Exclusion criteria

Exclusion criteria: Type 1 diabetes. Type 2 diabetes. GDM who had been treated with insulin before enrollment of the study.

Design outcomes

Primary

Measure	Time frame
Insulin requirement during pregnancy	—

Secondary

Measure	Time frame
Perinatal mortality. Development of type 2 diabetes after delivery.	—

Countries

Japan

Contacts

Public ContactIchiro Horie

Nagasaki University Department of Endocrinology and Metabolism

holy197741@me.com095-819-7200

Outcome results